Cidara Therapeutics (CDTX) Insider Trading & Ownership $16.43 -1.39 (-7.80%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$16.42 -0.01 (-0.07%) As of 04/4/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cidara Therapeutics (NASDAQ:CDTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.64%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$105,680.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$86,231.88 Get CDTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cidara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CDTX Insider Buying and Selling by Quarter Remove Ads Cidara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2025Leslie TariInsiderSell1,773$21.96$38,935.08 3/11/2025Shane WardCOOSell1,664$21.96$36,541.44 9/11/2024Taylor SandisonInsiderSell924$11.64$10,755.36 6/7/2024Jeffrey SteinCEOBuy8,000$13.21$105,680.00 (Data available from 1/1/2013 forward) CDTX Insider Trading Activity - Frequently Asked Questions Who is on Cidara Therapeutics's Insider Roster? The list of insiders at Cidara Therapeutics includes Jeffrey Stein, Leslie Tari, Paul Daruwala, Preetam Shah, Shane Ward, and Taylor Sandison. Learn more on insiders at CDTX. What percentage of Cidara Therapeutics stock is owned by insiders? 7.64% of Cidara Therapeutics stock is owned by insiders. Learn more on CDTX's insider holdings. Which Cidara Therapeutics insiders have been buying company stock? The following insiders have purchased CDTX shares in the last 24 months: Jeffrey Stein ($153,680.00), and Leslie Tari ($9,700.00). How much insider buying is happening at Cidara Therapeutics? Insiders have purchased a total of 11,000 CDTX shares in the last 24 months for a total of $163,380.00 bought. Which Cidara Therapeutics insiders have been selling company stock? The following insiders have sold CDTX shares in the last 24 months: Leslie Tari ($70,555.48), Preetam Shah ($12,676.40), Shane Ward ($50,249.64), and Taylor Sandison ($10,755.36). How much insider selling is happening at Cidara Therapeutics? Insiders have sold a total of 8,304 Cidara Therapeutics shares in the last 24 months for a total of $144,236.88 sold. Cidara Therapeutics Key ExecutivesDr. Jeffrey L. Stein Ph.D. (Age 69)President, CEO & Executive Director Compensation: $603.7kMr. Shane M. Ward (Age 49)Chief Legal Officer,Corporate Secretary & COO Compensation: $464.54k1 recent tradesDr. Taylor Sandison M.D. (Age 52)M.P.H., Chief Medical Officer Compensation: $497kDr. Kevin M. Forrest Ph.D. (Age 47)Founder and Chief Strategy Officer Compensation: $333.31kDr. Preetam Shah M.B.A. (Age 51)Ph.D., CFO, Chief Business Officer & Principal Accounting Officer Compensation: $577.85kMs. Allison Lewis CCPSPHR, Senior Vice President of People & CultureDr. Leslie Tari Ph.D. (Age 56)Chief Scientific Officer Compensation: $845.1kMs. Laura A. NavaltaSenior Vice President of Clinical OperationsDr. Nicole Davarpanah J.D.M.D., Senior VP of Translational Research & Development More Insider Trading Tools from MarketBeat Related Companies Mineralys Therapeutics Insider Buying Nurix Therapeutics Insider Buying Vir Biotechnology Insider Buying Intellia Therapeutics Insider Buying Collegium Pharmaceutical Insider Buying Arcus Biosciences Insider Buying Rocket Pharmaceuticals Insider Buying Xencor Insider Buying Zymeworks Insider Buying Xeris Biopharma Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Casey’s General Stores Insider Buys Shares of This Must-Own StockNVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish This page (NASDAQ:CDTX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
